273 results match your criteria: "a AbbVie Bioresearch Center; Global Biologics ; Worcester[Affiliation]"
Nat Commun
December 2024
Department of Biomedicine, Aarhus University, 8000, Aarhus C, Denmark.
Int J Mol Sci
December 2024
AbbVie Inc., 1 North Waukegan Rd., North Chicago, IL 60064, USA.
Alterations to post-translational crosslinking modifications in the extracellular matrix (ECM) are known to drive the pathogenesis of fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Thus, the methodology for measuring crosslinking dynamics is valuable for understanding disease progression. The existing crosslinking analysis sample preparation and liquid chromatography tandem mass spectrometry (LC-MS/MS) methods are typically labor-intensive and time-consuming which limits throughput.
View Article and Find Full Text PDFToxicol Pathol
December 2024
Janssen Research & Development, LLC, La Jolla, California, USA.
Pathology, a fundamental discipline that bridges basic scientific discovery to the clinic, is integral to successful drug development. Intrinsically multimodal and multidimensional, anatomic pathology continues to be empowered by advancements in molecular and digital technologies enabling the spatial tissue detection of biomolecules such as genes, transcripts, and proteins. Over the past two decades, breakthroughs in spatial molecular biology technologies and advancements in automation and digitization of laboratory processes have enabled the implementation of higher throughput assays and the generation of extensive molecular data sets from tissue sections in biopharmaceutical research and development research units.
View Article and Find Full Text PDFJ Chromatogr A
January 2025
Analytical Development, BDL, PDS&T, AbbVie Bioresearch Center, 100 Research Drive, Worcester, MA 01605, USA; Previously Purification Development, BDL, PDS&T, AbbVie Bioresearch Center, 100 Research Drive, Worcester, MA 01605, USA.
Significant aggregation challenges were encountered during the manufacturing processing of an immunocytokine diabody fusion protein. To mitigate this issue and reduce aggregates in the purification process, a variety of depth filters were evaluated for harvest clarification and post-Protein A intermediate filtration. Emphaze™ AEX Hybrid Purifier, a fully synthetic quaternary amine functionalized anion exchange (AEX) nonwoven filter, was found to be particularly effective in removing aggregates during both harvest clarification and post-Protein A intermediate filtration steps.
View Article and Find Full Text PDFJ Pharm Sci
November 2024
Biologics Drug Product Development, AbbVie Bioresearch Center, Worcester, MA 01605, United States. Electronic address:
Adeno-Associated Virus (AAV) is often selected as the vector of choice for gene therapy due to its superior clinical performance compared to other gene delivery systems. Currently the characterization of AAV degradation, especially the chemical degradation of capsid, has been limited due to lack of suitable methods. Our study using AAV9 as a model molecule shows that anion exchange chromatography (AEX) as a charge-based separation method has limitations in monitoring the chemical degradation of AAV9 capsid due to a confounding effect from DNA cargo ejection.
View Article and Find Full Text PDFJ Crohns Colitis
November 2024
Department of Medicine (Division of Gastroenterology) and Farncombe Family Digestive Health Research Institute; McMaster University, Hamilton ON, Canada.
Introduction: The Modified Multiplier of the SES-CD (MM-SES-CD) refines the assessment of endoscopic Crohn's Disease (CD) severity by differentially weighting parameters in the original SES-CD. A threshold of <22.5 for MM-SES-CD suggests endoscopic remission and correlates with a low risk of long-term disease progression.
View Article and Find Full Text PDFBioanalysis
November 2024
AbbVie Deutschland GmbH & Co. KG, Knollstr., Rhineland-Palatinate, Ludwigshafen, 67061, Germany.
Repulsive guidance molecule A (RGMa) is upregulated in neurodegenerative diseases. To assess RGMa levels in human serum and cerebrospinal fluid (CSF), a quantification method was developed and validated according to ICH M10 guideline. Sample preparation consisted of immunoprecipitation (IP, only for serum), digestion and purification followed by MS.
View Article and Find Full Text PDFAlzheimers Dement
November 2024
Highly qualified expert, Philadelphia, Pennsylvania, USA.
ACR Open Rheumatol
December 2024
AbbVie Bioresearch Center, Worcester, Massachusetts.
J Crohns Colitis
October 2024
Genomic Research Center, AbbVie Inc, Cambridge, MA.
Clin Gastroenterol Hepatol
September 2024
Division of Digestive Diseases, Imperial College London, London, United Kingdom.
Heliyon
August 2024
AbbVie Inc., North Chicago, IL, United States.
Nat Commun
August 2024
Ring Therapeutics, 140 First Street Suite 300, Cambridge, MA, 02139, USA.
JAMA Netw Open
August 2024
Northern California Institute for Research and Education, Department of Veterans Affairs Medical Center, San Francisco.
Importance: Black or African American (hereinafter, Black) and Hispanic or Latino/a/x (hereinafter, Latinx) adults are disproportionally affected by Alzheimer disease, but most research studies do not enroll adequate numbers of both of these populations. The Alzheimer's Disease Neuroimaging Initiative-3 (ADNI3) launched a diversity taskforce to pilot a multipronged effort to increase the study inclusion of Black and Latinx older adults.
Objective: To describe and evaluate the culturally informed and community-engaged inclusion efforts to increase the screening and enrollment of Black and Latinx older adults in ADNI3.
Antib Ther
July 2024
Biotherapeutics and Genetic Medicine, AbbVie Bioresearch Center, Worcester, MA 01605, United States.
Acta Neuropathol Commun
July 2024
AbbVie Deutschland GmbH & Co. KG, Neuroscience Research, Knollstrasse, 67061, Ludwigshafen, Germany.
J Chem Theory Comput
July 2024
Thomas Young Centre and Department of Chemical Engineering, University College London, London WC1E 7JE, U.K.
Computing free energy differences between metastable states characterized by nonoverlapping Boltzmann distributions is often a computationally intensive endeavor, usually requiring chains of intermediate states to connect them. Targeted free energy perturbation (TFEP) can significantly lower the computational cost of FEP calculations by choosing a set of invertible maps used to directly connect the distributions of interest, achieving the necessary statistically significant overlaps without sampling any intermediate states. Probabilistic generative models (PGMs) based on normalizing flow architectures can make it much easier via machine learning to train invertible maps needed for TFEP.
View Article and Find Full Text PDFAging (Albany NY)
June 2024
AbbVie Bioresearch Center, Worcester, MA 01605, USA.
Idiopathic pulmonary fibrosis (IPF) is an age-related disease with poor prognosis and limited therapeutic options. Activation of lung fibroblasts and differentiation to myofibroblasts are the principal effectors of disease pathology, but damage and senescence of alveolar epithelial cells, specifically type II (ATII) cells, has recently been identified as a potential trigger event for the progressive disease cycle. Targeting ATII senescence and the senescence-associated secretory phenotype (SASP) is an attractive therapeutic strategy; however, translatable primary human cell models that enable mechanistic studies and drug development are lacking.
View Article and Find Full Text PDFClin Exp Rheumatol
November 2024
AbbVie Bioresearch Center, Worcester, MA, USA.
Objectives: The aim of these studies was to characterise the molecular effects of a tool JAK1 inhibitor on cultured primary fibroblast-like synoviocytes (FLS) from patients with rheumatoid arthritis (RA) through both total and individual cell analysis.
Methods: RA-FLS cultures from 6 (Bulk RNA-seq) or 4 (ScRNA-seq) donors were pre-treated with various concentrations (100 nM and 1μM) of ABT-317 with/without exposure to 25% SEB-conditioned PBMC medium to mimic the RA inflammatory milieu. Cells were subjected to both bulk RNA-seq (36 libraries) and single cell RNA-seq (scRNA-seq; 24 libraries) to identify biological processes impacted by CM and ABT-317 treatments.
J Pharm Sci
September 2024
Biologics Drug Product Development, AbbVie Bioresearch Center, Worcester, MA 01605, United States. Electronic address:
The use of recombinant adeno-associated virus (AAV) vectors is a popular choice for in vivo gene therapy, with hundreds of ongoing clinical trials targeting various genetic diseases. However, due to limited material availability and the complexity of AAV structure, there is a critical lack of comprehensive studies on AAV degradation pathways. In this study, we intended to elucidate the degradation pathways for a model AAV9 with GFP as the transgene under relevant stressed conditions.
View Article and Find Full Text PDFInt J Mol Sci
May 2024
AbbVie Bioresearch Center, Worcester, MA 01605, USA.
JCI Insight
May 2024
AbbVie Bay Area, South San Francisco, California, USA.
DC inhibitory receptor (DCIR) is a C-type lectin receptor selectively expressed on myeloid cells, including monocytes, macrophages, DCs, and neutrophils. Its role in immune regulation has been implicated in murine models and human genome-wide association studies, suggesting defective DCIR function associates with increased susceptibility to autoimmune diseases such as rheumatoid arthritis, lupus, and Sjögren's syndrome. However, little is known about the mechanisms underlying DCIR activation to dampen inflammation.
View Article and Find Full Text PDFJ Med Chem
June 2024
AbbVie Bioresearch Center, 381 Plantation Street, Worcester, Massachusetts 01605, United States.
Mol Brain
May 2024
AbbVie, Cambridge Research Center, 200 Sidney Street Cambridge, Cambridge, MA, 02139, USA.
Aggregation of misfolded α-synuclein (α-syn) is a key characteristic feature of Parkinson's disease (PD) and related synucleinopathies. The nature of these aggregates and their contribution to cellular dysfunction is still not clearly elucidated. We employed mass spectrometry-based total and phospho-proteomics to characterize the underlying molecular and biological changes due to α-syn aggregation using the M83 mouse primary neuronal model of PD.
View Article and Find Full Text PDF